Genetic Signatures is a biotech company specialized in molecular diagnostics. Genetic Signatures has released its proprietary platform technology, 3Base, leading to seveal real-time PCR based products for the routine detection of infectious diseases named EasyScreen. This proprietary technology enables the screening of a wide array of infectious pathogens with a high degree of specificity in a rapid time to result manner.
Viralytics is a biotech company focusing on the development of oncolytic immunotherapies, using the specific property of certain viruses to preferentially infect and kill cancer cells. Viralytics’ lead product candidate is CAVATAK, a proprietary formulation of the common Coxsackievirus Type A21 (CVA21), evaluated in Phase 1 and 2 clinical trials.
DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.
Innate Immunotherapeutics is a medical biotechnology company designing and producing a unique immunomodulator microparticle technology. This innovative technology is able to induce the human immune system to fight certain types of cancer or infections, but also to modulate certain immune mechanisms implicated in autoimmune diseases (like the ones implicated in Multiple Sclerosis).
